Papers

1

Total Citations

6

H-Index

1

About

Fred Racine has established himself as a key innovator in the field of antibacterial pharmacodynamics, with a focused expertise in developing automated platforms for bacterial growth measurement. His most cited work, a 2022 study on a fully automated agar-based platform, addresses a critical bottleneck in dynamic in vitro antibacterial research: the labor-intensive sampling required to monitor bacterial load over time. By automating this process, Racine’s contribution enables more efficient and high-resolution tracking of bacterial pharmacodynamics, directly supporting the design of effective dosing strategies before animal model translation. This work has garnered 6 citations, reflecting its practical impact on streamlining preclinical workflows. Racine’s research sits at the intersection of microbiology, automation, and pharmacokinetics, offering tools that reduce manual error and increase throughput in antibacterial studies. His achievements highlight a commitment to solving real-world experimental challenges, making him a valuable resource for researchers seeking to optimize in vitro models of infection.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Development of a fully automated platform for agar-based measurement of viable bacterial growth
6 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago